Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) Ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate
The antiangiogenic agent Neovastat (Æ-941) stimulates tissue plasminogen activator activity
Recent advances in brain tumor therapy : local intracerebral drug delivery by polymers
Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients
A Phase II study of intravenous exatecan mesylate (dx-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose chop chemotherapy : Results of a Phase II study
A Phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer
Phase II study of interferon gamma in malignant carcinoid tumors (E9292) : A trial of the eastern cooperative oncology group
Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer : A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)
Gemcitabine and Cisplatin for patients with metastatic or recurrent esophageal carcinoma : A Southwest Oncology Group study